Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
healthcare policy
Fierce Biotech
A divisive bill seeks to limit biotech investment in China
Two federal lawmakers have introduced a bill seeking to apply the review requirements of the COINS Act to investments in Chinese biotechnology.
Will Maddox
Jun 4, 2026 10:54am
Avalere names new policy VP amid regulatory turbulence
Dec 16, 2025 11:30am
Regulatory, policy uncertainties harm biopharma planning: Cytiva
Oct 8, 2025 3:11pm
Marketing policy experts unfazed by threats to DTC advertising
Sep 12, 2025 4:20pm
PhRMA lays out 2025 goals ahead of meeting with Trump
Feb 20, 2025 7:51am
Biopharma status quo likely to persist under Trump 2.0: analyst
Nov 21, 2024 1:15pm
